First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia.
Strain D958, a methicillin-resistant Staphylococcus aureus strain with reduced susceptibility to vancomycin, was isolated from a 69-year-old Saudi male patient presenting with severe sepsis immediately after admission. Despite high serum levels of vancomycin, the same S. aureus strain was isolated from five blood culture sets during 1 week. Treatment failure under therapeutic levels of vancomycin prompted us to investigate the resistance profile of this strain in further detail. The MIC values for vancomycin as determined by Etest and microdilution were 3.0 and 2.0 mg/liter, respectively, and remained unchanged during the treatment course. The macro-Etest method showed a MIC of 4 mg/liter. The strain showed liquid vancomycin and lysostaphin MBCs of 2.0 and 5.0 mg/liter, respectively. The isolates were confirmed as heterogeneously vancomycin-intermediate S. aureus (hVISA) by vancomycin population analysis profile. The areas under these curves were similar for Mu3 and D958 for vancomycin and teicoplanin (ratio values were 1 and 1.1 for vancomycin and teicoplanin, respectively). Extensive genotyping and molecular characterization demonstrated that the strain harbored a staphylococcal cassette chromosome mec element (SCCmec) type III cassette and was of sequence type ST241, a single-locus variant of the successful multiresistant clone ST239. Microarray results demonstrated that D958 contained numerous resistance determinants (generally plasmid or phage encoded). These results suggest that this strain is constitutively expressing an altered susceptibility to vancomycin. Further studies are warranted to assess the clonal distribution of such strains displaying reduced susceptibility to vancomycin prior to any antimicrobial therapy.
Al-Obeid
S
S
Microbiology Department, Security Forces Hospital Program, Kingdom of Saudi Arabia, P.O. Box 3643, Riyadh 11481, Saudi Arabia. obeid_jacques@hotmail.com
Haddad
Q
Q
Cherkaoui
A
A
Schrenzel
J
J
François
P
P
D000368:Aged; D000900:Anti-Bacterial Agents / Q000032:analysis / Q000494:pharmacology* / Q000627:therapeutic use; D015373:Bacterial Typing Techniques; D001769:Blood / Q000382:microbiology; D002876:Chromosomes, Bacterial; D016000:Cluster Analysis; D016172:DNA Fingerprinting; D004269:DNA, Bacterial / Q000235:genetics; D005798:Genes, Bacterial; D005838:Genotype; D006801:Humans; D008248:Lysostaphin / Q000494:pharmacology; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification*; D046228:Microarray Analysis; D008826:Microbial Sensitivity Tests; D050296:Microbial Viability / Q000187:drug effects; D010957:Plasmids; D012529:Saudi Arabia; D018805:Sepsis / Q000382:microbiology*; D044967:Serum / Q000737:chemistry; D013203:Staphylococcal Infections / Q000382:microbiology*; D017334:Teicoplanin / Q000494:pharmacology; D014640:Vancomycin / Q000032:analysis / Q000494:pharmacology* / Q000627:therapeutic use; D020713:Vancomycin Resistance
D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D017334:Teicoplanin; D014640:Vancomycin; D008248:Lysostaphin
N Engl J Med. 2003 Apr 3;348(14):1342-7
12672861
J Clin Microbiol. 2004 Jun;42(6):2398-402
15184410
Antimicrob Agents Chemother. 2003 Jun;47(6):2036-9
12760894
J Clin Microbiol. 2007 Feb;45(2):329-32
17108069
J Clin Microbiol. 1999 Nov;37(11):3590-3
10523558
J Hosp Infect. 2007 Jun;65 Suppl 2:105-9
17540252
Lancet. 1998 Apr 18;351(9110):1212
9643727
J Clin Microbiol. 2008 Sep;46(9):2950-4
18632899
Clin Microbiol Infect. 2005 May;11(5):405-7
15819869
Clin Microbiol Infect. 2006 Apr;12 Suppl 2:3-10
16524422
Emerg Infect Dis. 2004 May;10(5):855-7
15200819
Ann Clin Microbiol Antimicrob. 2006 Dec 02;5:30
17140452
Clin Infect Dis. 1993 Sep;17(3):313-20; quiz 321-2
8218670
Ann Saudi Med. 2002 Jan-Mar;22(1-2):4-7
17259757
J Clin Microbiol. 2000 Mar;38(3):1008-15
10698988
BMC Genomics. 2006 Nov 22;7:296
17121677
J Clin Microbiol. 2006 Nov;44(11):3883-6
16957043
Antimicrob Agents Chemother. 2003 Oct;47(10):3040-5
14506006
Lancet. 1999 May 8;353(9164):1587-8
10334262
Diagn Microbiol Infect Dis. 2003 Feb;45(2):149-52
12614988
BMC Genomics. 2005 Jun 17;6:95
15963225
Clin Infect Dis. 2003 Feb 15;36(4):429-39
12567300
Emerg Infect Dis. 2008 Feb;14(2):304-7
18258126
Can J Microbiol. 2007 Aug;53(8):931-6
17898849
J Clin Microbiol. 2001 Feb;39(2):591-5
11158112
J Bacteriol. 2006 Feb;188(3):1120-33
16428416
Clin Infect Dis. 2007 May 1;44(9):1208-15
17407040
J Clin Microbiol. 2006 Mar;44(3):1040-8
16517892
Science. 2003 Nov 28;302(5650):1569-71
14645850
J Clin Microbiol. 2005 Jul;43(7):3346-55
16000459
Clin Infect Dis. 2004 Feb 15;38(4):521-8
14765345
Lancet. 2001 Apr 21;357(9264):1225-40
11418146
Antimicrob Agents Chemother. 2008 Oct;52(10):3755-62
18644967
Antimicrob Agents Chemother. 2005 Jul;49(7):2687-92
15980337
J Clin Microbiol. 2001 Dec;39(12):4445-51
11724859
Clin Microbiol Infect. 2003 Dec;9(12):1179-86
14686982
J Clin Microbiol. 2000 Oct;38(10):3879-81
11015427
Biol Direct. 2009 Jan 13;4:1
19144117
Am J Med. 1986 Jul;81(1):43-52
3524225
MMWR Morb Mortal Wkly Rep. 2002 Oct 11;51(40):902
12418544
Clin Infect Dis. 2007 Nov 1;45(9):1132-40
17918074
Med J Aust. 2001 Nov 5;175(9):480-3
11758077
J Clin Microbiol. 2008 Apr;46(4):1520-2
18234867
Clin Infect Dis. 2008 Mar 1;46(5):668-74
18257700
J Antimicrob Chemother. 2002 Dec;50(6):1017-26
12461026
J Clin Microbiol. 2005 Nov;43(11):5445-51
16272468
Clin Infect Dis. 2005 Sep 15;41(6):771-7
16107972
J Antimicrob Chemother. 2006 Jan;57(1):146-9
16286482
Antimicrob Agents Chemother. 2008 Dec;52(12):4510-3
18838583
Clin Infect Dis. 2004 Apr 15;38(8):1188-91
15095227
J Antimicrob Chemother. 2000 Feb;45(2):258-9
10660514
J Antimicrob Chemother. 2001 Feb;47(2):163-70
11157900
Proc Natl Acad Sci U S A. 2007 May 29;104(22):9451-6
17517606
Rev Assoc Med Bras (1992). 1995 Jan-Feb;41(1):47-52
7550414
Int J Antimicrob Agents. 2000 Nov;16 Suppl 1:S31-4
11137406
Antimicrob Agents Chemother. 2009 Sep;53(9):3642-9
19546358
J Clin Microbiol. 2003 Jan;41(1):5-14
12517819
Lancet. 1997 Dec 6;350(9092):1670-3
9400512
Antimicrob Agents Chemother. 2004 Jun;48(6):1953-9
15155184
J Antimicrob Chemother. 2006 Apr;57(4):699-704
16464892
Eur J Clin Microbiol Infect Dis. 2001 Oct;20(10):685-97
11757969
Am J Med. 1998 May 29;104(5A):7S-10S
9684652
J Antimicrob Chemother. 2004 Dec;54(6):1045-50
15531598